These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 18019671)

  • 1. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
    Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
    Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycoses and their treatment in malignant hemopathies].
    Martino P; Girmenia C
    Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
    Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
    J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
    Karthaus M; Cornely OA
    Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of intracranial fungal infections in patients with haematological malignancies.
    Mattiuzzi G; Giles FJ
    Br J Haematol; 2005 Nov; 131(3):287-300. PubMed ID: 16225648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
    Bow EJ
    Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns and trends in systemic fungal infections.
    Richardson MD
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the molecular and serological diagnosis of invasive fungal infection in haemato-oncology patients.
    McLintock LA; Jones BL
    Br J Haematol; 2004 Aug; 126(3):289-97. PubMed ID: 15257700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions?
    Hummel M; Buchheidt D
    Mycoses; 2007; 50 Suppl 1():18-23. PubMed ID: 17394606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiologic consequences of new approaches to managing hematologic malignancies.
    Blijlevens NM; Donnelly JP; de Pauw BE
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.
    Pagano L; Caira M; Fianchi L
    Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in antifungal prevention and treatment.
    Groll AH; Tragiannidis A
    Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment.
    Caira M; Trecarichi EM; Mancinelli M; Leone G; Pagano L
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):881-92. PubMed ID: 21810058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies.
    Jensen HE; Salonen J; Ekfors TO
    J Pathol; 1997 Jan; 181(1):100-5. PubMed ID: 9072010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological diagnosis of systemic candidiasis and invasive aspergillosis.
    Holmberg K
    Scand J Infect Dis Suppl; 1978; (16):26-32. PubMed ID: 107579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular and immunological methods applied in diagnosis of mycoses].
    Kuba K
    Wiad Parazytol; 2008; 54(3):187-97. PubMed ID: 19055059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.